Reviews Estring


No reviews yet.

Estring Drug Description
ESTRING®
(estradiol) Vaginal Ring

WARNINGS
ENDOMETRIAL CANCER
Adequate diagnostic measures, including endometrial sampling when indicated,
should be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS
Estrogens with or without progestins should not be used for the prevention
of cardiovascular disease or dementia. (See Clinical
Studies and WARNINGS, Cardiovascular
disorders and Dementia.)
The Women's Health Initiative (WHI) estrogen alone substudy reported increased
risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50
to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment
with daily oral conjugated estrogens (CE 0.625 mg) relative to placebo. (See
Clinical Studies and WARNINGS,
Cardiovascular disorders.)
The estrogen plus progestin WHI substudy reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal
women (50 to 79 years of age) during 5.6 years of treatment with daily oral
CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative
to placebo. (See Clinical Studies and WARNINGS,
Cardiovascular disorders and Malignant neoplasms, Breast cancer.)
The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI,
reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 5.2 years of treatment with daily CE
0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined
with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies
to younger postmenopausal women. (See Clinical
Studies and WARNINGS, Dementia and
PRECAUTIONS, Geriatric Use.)
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol (Estrace Vaginal Cream, Estring)?

Estradiol increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, while using estradiol lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together while using estradiol. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estradiol long-term...
Read All Potential Side Effects for Estring »




ESTRING® (estradiol vaginal ring) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers and barium sulfate are combined to form the ring. When placed in the vagina, ESTRING releases estradiol, approximately 7.5 mcg per 24 hours, in a consistent stable manner over 90 days. ESTRING has the following dimensions: outer diameter 55 mm; cross-sectional diameter 9 mm; core diameter 2 mm. One ESTRING should be inserted into the upper third of the vaginal vault, to be worn continuously for three months.
Estradiol is chemically described as estra-1,3,5(10)-triene-3,17β-diol.
The molecular formula of estradiol is C18H24O2
and the structural formula is:








The molecular weight of estradiol is 272.39.Last reviewed on RxList: 10/16/2008




Estring Drug Description
ESTRING®
(estradiol) Vaginal Ring

WARNINGS
ENDOMETRIAL CANCER
Adequate diagnostic measures, including endometrial sampling when indicated,
should be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS
Estrogens with or without progestins should not be used for the prevention
of cardiovascular disease or dementia. (See Clinical
Studies and WARNINGS, Cardiovascular
disorders and Dementia.)
The Women's Health Initiative (WHI) estrogen alone substudy reported increased
risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50
to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment
with daily oral conjugated estrogens (CE 0.625 mg) relative to placebo. (See
Clinical Studies and WARNINGS,
Cardiovascular disorders.)
The estrogen plus progestin WHI substudy reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal
women (50 to 79 years of age) during 5.6 years of treatment with daily oral
CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative
to placebo. (See Clinical Studies and WARNINGS,
Cardiovascular disorders and Malignant neoplasms, Breast cancer.)
The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI,
reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 5.2 years of treatment with daily CE
0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined
with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies
to younger postmenopausal women. (See Clinical
Studies and WARNINGS, Dementia and
PRECAUTIONS, Geriatric Use.)
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol (Estrace Vaginal Cream, Estring)?

Estradiol increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, while using estradiol lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together while using estradiol. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estradiol long-term...
Read All Potential Side Effects for Estring »




ESTRING® (estradiol vaginal ring) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers and barium sulfate are combined to form the ring. When placed in the vagina, ESTRING releases estradiol, approximately 7.5 mcg per 24 hours, in a consistent stable manner over 90 days. ESTRING has the following dimensions: outer diameter 55 mm; cross-sectional diameter 9 mm; core diameter 2 mm. One ESTRING should be inserted into the upper third of the vaginal vault, to be worn continuously for three months.
Estradiol is chemically described as estra-1,3,5(10)-triene-3,17β-diol.
The molecular formula of estradiol is C18H24O2
and the structural formula is:








The molecular weight of estradiol is 272.39.Last reviewed on RxList: 10/16/2008




Estring Drug Description
ESTRING®
(estradiol) Vaginal Ring

WARNINGS
ENDOMETRIAL CANCER
Adequate diagnostic measures, including endometrial sampling when indicated,
should be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS
Estrogens with or without progestins should not be used for the prevention
of cardiovascular disease or dementia. (See Clinical
Studies and WARNINGS, Cardiovascular
disorders and Dementia.)
The Women's Health Initiative (WHI) estrogen alone substudy reported increased
risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50
to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment
with daily oral conjugated estrogens (CE 0.625 mg) relative to placebo. (See
Clinical Studies and WARNINGS,
Cardiovascular disorders.)
The estrogen plus progestin WHI substudy reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal
women (50 to 79 years of age) during 5.6 years of treatment with daily oral
CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative
to placebo. (See Clinical Studies and WARNINGS,
Cardiovascular disorders and Malignant neoplasms, Breast cancer.)
The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI,
reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 5.2 years of treatment with daily CE
0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined
with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies
to younger postmenopausal women. (See Clinical
Studies and WARNINGS, Dementia and
PRECAUTIONS, Geriatric Use.)
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol (Estrace Vaginal Cream, Estring)?

Estradiol increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, while using estradiol lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together while using estradiol. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estradiol long-term...
Read All Potential Side Effects for Estring »




ESTRING® (estradiol vaginal ring) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers and barium sulfate are combined to form the ring. When placed in the vagina, ESTRING releases estradiol, approximately 7.5 mcg per 24 hours, in a consistent stable manner over 90 days. ESTRING has the following dimensions: outer diameter 55 mm; cross-sectional diameter 9 mm; core diameter 2 mm. One ESTRING should be inserted into the upper third of the vaginal vault, to be worn continuously for three months.
Estradiol is chemically described as estra-1,3,5(10)-triene-3,17β-diol.
The molecular formula of estradiol is C18H24O2
and the structural formula is:








The molecular weight of estradiol is 272.39.Last reviewed on RxList: 10/16/2008




Estring Drug Description
ESTRING®
(estradiol) Vaginal Ring

WARNINGS
ENDOMETRIAL CANCER
Adequate diagnostic measures, including endometrial sampling when indicated,
should be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS
Estrogens with or without progestins should not be used for the prevention
of cardiovascular disease or dementia. (See Clinical
Studies and WARNINGS, Cardiovascular
disorders and Dementia.)
The Women's Health Initiative (WHI) estrogen alone substudy reported increased
risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50
to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment
with daily oral conjugated estrogens (CE 0.625 mg) relative to placebo. (See
Clinical Studies and WARNINGS,
Cardiovascular disorders.)
The estrogen plus progestin WHI substudy reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal
women (50 to 79 years of age) during 5.6 years of treatment with daily oral
CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative
to placebo. (See Clinical Studies and WARNINGS,
Cardiovascular disorders and Malignant neoplasms, Breast cancer.)
The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI,
reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 5.2 years of treatment with daily CE
0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined
with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies
to younger postmenopausal women. (See Clinical
Studies and WARNINGS, Dementia and
PRECAUTIONS, Geriatric Use.)
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol (Estrace Vaginal Cream, Estring)?

Estradiol increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, while using estradiol lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together while using estradiol. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estradiol long-term...
Read All Potential Side Effects for Estring »




ESTRING® (estradiol vaginal ring) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers and barium sulfate are combined to form the ring. When placed in the vagina, ESTRING releases estradiol, approximately 7.5 mcg per 24 hours, in a consistent stable manner over 90 days. ESTRING has the following dimensions: outer diameter 55 mm; cross-sectional diameter 9 mm; core diameter 2 mm. One ESTRING should be inserted into the upper third of the vaginal vault, to be worn continuously for three months.
Estradiol is chemically described as estra-1,3,5(10)-triene-3,17β-diol.
The molecular formula of estradiol is C18H24O2
and the structural formula is:








The molecular weight of estradiol is 272.39.Last reviewed on RxList: 10/16/2008




Estring Drug Description
ESTRING®
(estradiol) Vaginal Ring

WARNINGS
ENDOMETRIAL CANCER
Adequate diagnostic measures, including endometrial sampling when indicated,
should be undertaken to rule out malignancy in all cases of undiagnosed persistent
or recurring abnormal vaginal bleeding. (See WARNINGS,
Malignant neoplasms, Endometrial cancer.) CARDIOVASCULAR AND OTHER RISKS
Estrogens with or without progestins should not be used for the prevention
of cardiovascular disease or dementia. (See Clinical
Studies and WARNINGS, Cardiovascular
disorders and Dementia.)
The Women's Health Initiative (WHI) estrogen alone substudy reported increased
risks of stroke and deep vein thrombosis (DVT) in postmenopausal women (50
to 79 years of age) during 6.8 years and 7.1 years, respectively, of treatment
with daily oral conjugated estrogens (CE 0.625 mg) relative to placebo. (See
Clinical Studies and WARNINGS,
Cardiovascular disorders.)
The estrogen plus progestin WHI substudy reported increased risks of myocardial
infarction, stroke, invasive breast cancer, pulmonary emboli, and DVT in postmenopausal
women (50 to 79 years of age) during 5.6 years of treatment with daily oral
CE 0.625 mg combined with medroxyprogesterone acetate (MPA 2.5 mg), relative
to placebo. (See Clinical Studies and WARNINGS,
Cardiovascular disorders and Malignant neoplasms, Breast cancer.)
The Women's Health Initiative Memory Study (WHIMS), a substudy of the WHI,
reported increased risk of developing probable dementia in postmenopausal
women 65 years of age or older during 5.2 years of treatment with daily CE
0.625 mg alone and during 4 years of treatment with daily CE 0.625 mg combined
with MPA 2.5 mg, relative to placebo. It is unknown whether this finding applies
to younger postmenopausal women. (See Clinical
Studies and WARNINGS, Dementia and
PRECAUTIONS, Geriatric Use.)
In the absence of comparable data, these risks should be assumed to be similar for other doses of CE and MPA and other combinations and dosage forms of estrogens and progestins. Because of these risks, estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman.

DRUG DESCRIPTION



What are the possible side effects of estradiol (Estrace Vaginal Cream, Estring)?

Estradiol increases the risk of developing a condition (endometrial hyperplasia) that may lead to cancer of the lining of the uterus. Taking progestins, another hormone drug, while using estradiol lowers the risk of developing this condition. Therefore, if your uterus has not been removed, your doctor may prescribe a progestin for you to take together while using estradiol. Visit your doctor regularly and report any unusual vaginal bleeding right away.
Treatment with estradiol long-term...
Read All Potential Side Effects for Estring »




ESTRING® (estradiol vaginal ring) is a slightly opaque ring with a whitish core containing a drug reservoir of 2 mg estradiol. Estradiol, silicone polymers and barium sulfate are combined to form the ring. When placed in the vagina, ESTRING releases estradiol, approximately 7.5 mcg per 24 hours, in a consistent stable manner over 90 days. ESTRING has the following dimensions: outer diameter 55 mm; cross-sectional diameter 9 mm; core diameter 2 mm. One ESTRING should be inserted into the upper third of the vaginal vault, to be worn continuously for three months.
Estradiol is chemically described as estra-1,3,5(10)-triene-3,17β-diol.
The molecular formula of estradiol is C18H24O2
and the structural formula is:








The molecular weight of estradiol is 272.39.Last reviewed on RxList: 10/16/2008





Other reviews about Estring on wordpress

About the Author
  by devzi11a
Rich Strickland works the info sphere as a software programmer, designer, architect and business analyst. He is the president of EString Software and spends his spare time or […]


Getting some more practice at the Toronto club
  by Hans
Decided at the last minute to attend the Toronto club.┬á I wanted to test out how successful my studying has been.┬á Just the basics tonight. Game #1 vs. Sharmaine […]


ESTRING® (estradiol) Vaginal Ring
  by kanlayanee
[caption id="" align="alignnone" width="288" caption="ESTRING 2 MG VAGINAL RING PHARMACIA/UPJHN Approx. Price: $167.24 per 1Each"][/caption] Adult Min/Max Dose: 7.5mcgAll insert 1 vaginal ring by […]


PREMPROÔäó,PREMPHASE┬« (conjugated estrogens/medroxyprogesterone acetate) Tablets
  by kanlayanee
[caption id="" align="alignnone" width="251" caption="Brand names Premphase┬«, Prempro┬«"][/caption] USES: This medication is used to reduce menopause symptoms. It helps reduce episodes of flushing and sweating of the upper body and […]


FDA Approved Bioidentical Hormones
  by bodylogicmd
We've mentioned that the FDA has approved over 20 bioidentical hormones and now want to share some of the hormones on that list, specifically those meant to treat […]


COBRA Update and Thoughts on the Cost of Prescription Medications
  by Chopstick
Squeaky wheels get oiled, right?┬á Isn't that the saying?┬á Perhaps my blog tirade did the trick, but whatever the case, I was (un)pleasantly woken up at 6:30┬áthis morning […]


Reusable shopping bags
  by livingedgeblog
We all know we should be using them, but frankly the green supermarket bags with the plastic bottoms aren't convenient when you drop by the shops on your […]


Sunday, May 31, 2009, Front Page Philippines ...
  by Front Page Philippines TV
in its entertainment segment, will air one Filipino rock tune, "Titser Enemy Number 1" -an original from the legendary "Juan dela Cruz Band". [caption id="attachment_1123" align="aligncenter" width="499" caption="L-R: Jose […]


string similarity and more
  by David Weldon
I added estring to github today. It's a string library which contains many useful functions including string similarity. Check this out: estring:similarity("ownage", "pwnage"). 0.8333333333333334 estring is also full of goodies like: estring:begins_with("fancy […]


Front Page Philippines Broadcast Advisory for Sunday, May 9, 2010
  by Front Page Philippines TV
[caption id="attachment_2115" align="alignleft" width="150" caption="THE ABLE MEN AND WOMEN OF THE PHILIPPINE CHAMBER OF COMMERCE-TORONTO (PCCT) led by their president, Rafael Nebres (first row, left) are joined by […]



Other reviews about Estring on web:

Estring information from Drugs.com. Estring is an estrogen replacement system for relief of the vaginal problems that often occur after menopause, including vaginal dryness ... Estring patient advice including side effects


Learn about the prescription medication Estring (Estradiol Vaginal Ring), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Estring (Estradiol Vaginal Ring) Drug Information: Uses, Side ...


1 ESTRING ® (estradiol vaginal ring) PHYSICIAN'S LEAFLET WARNINGS ENDOMETRIAL CANCER Adequate diagnostic measures, including endometrial sampling when indicated, should be ... Word version based on insert code 818 049 001


Accurate, FDA approved Estring information for healthcare professionals and patients - brought to you by Drugs.com. Estring Official FDA information, side effects and uses.


Consumer ratings reports for estring. Includes patient rankings on scale of 1-5, comments, side effects, sex, age, time taken. ESTRING: Side effects, ratings, and patient comments


Information on the Pfizer product ESTRING. ... ESTRING ® (estradiol vaginal ring) This product information is intended only for residents of the United States. ESTRING | Pfizer: the world's largest research-based ...


Estring - a low-dose estradiol-releasing ring, manufactured from silicone elastomer, for the treatment of vaginal atrophy. Femring - a low-dose estradiol-acetate releasing ring ... Vaginal ring - Wikipedia, the free encyclopedia


Menopause is a life-changing event for many women. Some report that they feel liberated while others struggle with some of the health issues and side effects of menopause like ... Estring - www.TheLadiesChoice.com Libido


Estring is a female hormone usually given to women who no longer are able to produce the proper amount of hormone (i. Side effects and interactions are available at drugstore ... Estring - drugstore.com. Low prices, side effects, interactions.


Consumer information about the medication ESTRADIOL - VAGINAL RING (Estring), includes side effects, drug interactions, recommended dosages, and storage information. Read more ... ESTRADIOL - VAGINAL RING (Estring) side effects, medical uses, and ...





Featured Reviews

Reviews Demulen

Demulen Drug Description DRUG DESCRIPTION The chemical name for ethyndiol diacetate is 19-nor-17alpha-pregn-4-en-20-yne-3beta,17-diol diacetate, and for ethinyl estradiol it is 19-nor- 17alpha-pregna-1,3,5 (10)-trien-20-yne-3,17-diol....
Read More  |  Review This
Reviews Ringers Injection

Ringers Injection Drug Description Lactated Ringer's Injection, USP in AVIVA Plastic Container DRUG DESCRIPTION Lactated Ringer's Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose...
Read More  |  Review This
Reviews Cetuximab

Erbitux Drug Description ERBITUX® (cetuximab) Solution for Intravenous Infusion WARNING: SERIOUS INFUSION REACTIONS and CARDIOPULMONARY ARREST Infusion Reactions: Serious infusion reactions occurred with the administration of...
Read More  |  Review This
Reviews Eryc

Eryc Drug Description ERYC® (erythromycin) Delayed-Release Capsules, USP To reduce the development of drug-resistant bacteria and maintain the effectiveness of ERYC® and other antibacterial drugs, ERYC should be used only to treat...
Read More  |  Review This
Reviews Doxil

Doxil Drug Description DOXIL® (doxorubicin HCl liposome injection) for Intravenous Infusion WARNING INFUSION REACTIONS, MYELOSUPPRESSION, CARDIOTOXICITY, LIVER IMPAIRMENT, ACCIDENTAL SUBSTITUTION The use of DOXIL (doxorubicin...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....